Author:
Gafforov Yusufjon,Rašeta Milena,Yarasheva Manzura,Wan-Mohtar Wan Abd Al Qadr Imad,Rapior Sylvie
Publisher
Springer International Publishing
Reference71 articles.
1. Adi G, Emsen B, Kaya A, Kocabas A, Cinar S, Kartal D (2015) Cytotoxicity of some edible mushrooms extracts over liver hepatocellular carcinoma cells in conjunction with their antioxidant and antibacterial properties. Pharmacogn Mag 11(11):S6–S18
2. Arya A, Al-Obaidi MM, Shahid N, Bin Noordin MI, Looi CY, Wong WF, Khaing SL, Mustafa MR (2014) Synergistic effect of quercetin and quinic acid by alleviating structural degeneration in the liver, kidney and pancreas tissues of STZ-induced diabetic rats: a mechanistic study. Food Chem Toxicol 71:183–196
3. Asatiani MD, Wasser SP, Nevo E, Ruimi N, Mahajna J, Reznik AZ (2011) The shaggy ink cap medicinal mushroom, Coprinus comatus (O.F.Mull.: Fr.) Pers. (Agaricomycetidae) substances interfere with H2O2 induction of the NF-κB pathway through inhibition of IκBα phosphorylation in MCF7 breast cancer cells. Int J Med Mushrooms 13(1):19–25
4. Barros L, Baptista P, Correia DM, Casal S, Oliveira B, Ferreira IC (2007) Fatty acid and sugar compositions and nutritional value of five wild edible mushrooms from northeast Portugal. Food Chem 105:140–145
5. Cao H, Wang S, Cui X, Guo H, Xi X, Xu F, Li Y, Zheng M, Han C (2019) Taking ingredients as an entry point to explore the relationship between the shaggy ink cap medicinal mushroom, Coprinus comatus (Agaricomycetes), and diabetes mellitus (review). Int J Med Mushrooms 21(5):493–502